A detailed history of Creative Planning transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Creative Planning holds 20,502 shares of ORGO stock, worth $79,137. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,502
Previous 21,869 6.25%
Holding current value
$79,137
Previous $61,000 4.92%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$2.42 - $3.24 $3,308 - $4,429
-1,367 Reduced 6.25%
20,502 $58,000
Q2 2024

Aug 15, 2024

BUY
$2.28 - $3.03 $49,861 - $66,263
21,869 New
21,869 $61,000
Q1 2023

May 15, 2023

BUY
$1.89 - $2.93 $43,694 - $67,738
23,119 New
23,119 $49,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.